Elisa Mariella

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

Journal: EMBO molecular medicine

Published: September 30, 2025

Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.

Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.

Journal: Nature reviews. Cancer

Published: July 29, 2024

Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer.

Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer.

Journal: Molecular oncology

Published: January 25, 2024

Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.

Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.

Journal: Journal of clinical pathology

Published: December 09, 2023

DNA demethylation triggers cell free DNA release in colorectal cancer cells.

DNA demethylation triggers cell free DNA release in colorectal cancer cells.

Journal: Genome medicine

Published: July 31, 2023

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.

Journal: Cell reports. Medicine

Published: April 16, 2023

Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Journal: Nature communications

Published: January 31, 2023

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).

Journal: Cell death & disease

Published: January 05, 2023

The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.

The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 09, 2022

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 18, 2022

Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Journal: Nature communications

Published: August 03, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026